We are live on ! Find out more
AONCW

American Oncology Network, Inc. Warrant
AONCW

Delisted

AONCW was delisted on the 7th of June, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in American Oncology Network, Inc. Warrant in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $15.7K → $0 (-$15.7K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$6.31K
2
SBLIC
Security Benefit Life Insurance Company
Kansas
-$6.22K
3
CS
Clear Street
New York
-$3.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
– -$6.31K -210,455 Closed
SBLIC
2
Security Benefit Life Insurance Company
Kansas
– -$6.22K -207,305 Closed
CS
3
Clear Street
New York
– -$3.16K -105,274 Closed

AONCW Hedge Fund Activity: Q3 2024 in Review

0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Warrant (AONCW) for Q3 2024, worth a combined $0 — down 100% from $15.7K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AONCW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Sachs, exiting entirely with an estimated $6.31K sold.

  • 0 institutional investors held American Oncology Network, Inc. Warrant (AONCW) as of Q3 2024, down from 3 in Q2 2024.
  • Funds reported $0 of American Oncology Network, Inc. Warrant stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new American Oncology Network, Inc. Warrant positions in Q3 2024 and 3 closed out, a net change of -3 holders.
  • The largest American Oncology Network, Inc. Warrant seller in Q3 2024 was Goldman Sachs, an estimated $6.31K sold.

Based on aggregated 13F filings for Q3 2024.